[go: up one dir, main page]

JP2001064279A - New selenium compounds - Google Patents

New selenium compounds

Info

Publication number
JP2001064279A
JP2001064279A JP24168699A JP24168699A JP2001064279A JP 2001064279 A JP2001064279 A JP 2001064279A JP 24168699 A JP24168699 A JP 24168699A JP 24168699 A JP24168699 A JP 24168699A JP 2001064279 A JP2001064279 A JP 2001064279A
Authority
JP
Japan
Prior art keywords
compound represented
formula
compound
embedded image
selenium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP24168699A
Other languages
Japanese (ja)
Other versions
JP4433521B2 (en
Inventor
Shuji Tomota
修司 友田
Michio Iwaoka
道夫 岩岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP24168699A priority Critical patent/JP4433521B2/en
Publication of JP2001064279A publication Critical patent/JP2001064279A/en
Application granted granted Critical
Publication of JP4433521B2 publication Critical patent/JP4433521B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

(57)【要約】 【課題】蛋白質中のシステイン残基によるジスルフィド
結合を形成あるいは切断できる試薬(変成剤)としてD
TT(Dithiothreitol)およびその誘導
体である1,2−dithiane−4,5−diol
が広く知られているが、DTT等はpHに大きく依存
し、pH8.0以上のアルカリ性条件下のみで反応が進
行するため、生体内の環境に近い中性付近での反応をお
こなうことができなかった。 【解決手段】中性付近で反応性の高い変成剤として、下
記の式(1)で表される化合物とそれを還元することに
よって得られる式(2)で表される化合物、および式
(3)で表される化合物とそれを酸化することによって
得られる式(4)で表される化合物等の新規セレン化合
物、およびそれらの製造方法を見出した。 【化1】 【化2】 【化3】 【化4】
PROBLEM TO BE SOLVED: To provide a reagent (denaturing agent) capable of forming or cleaving a disulfide bond by a cysteine residue in a protein.
TT (Dithiothreitol) and its derivative 1,2-dithane-4,5-diol
Although DTT and the like are widely known, DTT and the like largely depend on pH, and the reaction proceeds only under alkaline conditions of pH 8.0 or more, so that a reaction near neutrality close to the in vivo environment can be performed. Did not. Kind Code: A1 A compound represented by the following formula (1), a compound represented by the formula (2) obtained by reducing it, and a compound represented by the formula (3), which are highly reactive near neutrality: ), A novel selenium compound such as a compound represented by the formula (4) obtained by oxidizing the compound, and a method for producing them. Embedded image Embedded image Embedded image Embedded image

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は蛋白質中のシステイ
ン残基によるジスルフィド結合を形成あるいは切断でき
る試薬である新規なセレン化合物類とその製造方法に関
する。
TECHNICAL FIELD The present invention relates to a novel selenium compound which is a reagent capable of forming or cleaving a disulfide bond by a cysteine residue in a protein, and a method for producing the same.

【0002】[0002]

【従来の技術】蛋白質中のシステイン残基によるジスル
フィド結合を形成あるいは切断できる試薬(変成剤)と
してはDTT(Dithiothreitol=1,4
−ジメルカプト−2,3−ブタンジオール)およびその
誘導体である1,2−ジチアン−4,5−ジオールが広
く知られている。これらDTT等は有用な試薬であり、
蛋白質の立体構造形成過程を研究する手法に幅広く利用
されている。
2. Description of the Related Art As a reagent (denaturing agent) capable of forming or cleaving a disulfide bond by a cysteine residue in a protein, DTT (Dithiothreitol = 1,4) is known.
-Dimercapto-2,3-butanediol) and its derivative 1,2-dithiane-4,5-diol are widely known. These DTTs are useful reagents,
It is widely used for studying the process of protein three-dimensional structure formation.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、上記の
DTT等はpHに大きく依存し、pH8以上のアルカリ
性条件下のみで反応が進行するため、生体内の環境に近
い中性付近での反応をおこなうことができなかった。す
なわち、中性付近で反応性の高い変成剤の開発が望まれ
ている。
However, the above-mentioned DTT and the like greatly depend on pH, and the reaction proceeds only under alkaline conditions of pH 8 or more, so that the reaction takes place near neutrality close to the in vivo environment. I couldn't do that. That is, there is a demand for the development of a modifying agent having high reactivity near neutrality.

【0004】[0004]

【課題を解決するための手段】本発明者らは、中性付近
で反応性の高い変成剤について鋭意研究した結果、下記
の式(1)で表される化合物とそれを還元することによ
って得られる式(2)で表される化合物、および式
(3)で表される化合物とそれを酸化することによって
得られる式(4)で表される化合物等の新規セレン化合
物類およびそれらの製造方法を見出した。
Means for Solving the Problems The present inventors have conducted intensive studies on a modifying agent having high reactivity near neutrality, and as a result, obtained by reducing a compound represented by the following formula (1) and a compound represented by the following formula (1). Novel selenium compounds such as a compound represented by the formula (2), a compound represented by the formula (3) and a compound represented by the formula (4) obtained by oxidizing the compound, and methods for producing them Was found.

【0005】すなわち、本発明は下記の構成からなるも
のである。 [1]式(1)で表される化合物。
That is, the present invention has the following constitution. [1] A compound represented by the formula (1).

【化6】 Embedded image

【0006】[2]式(2)で表される化合物。[2] A compound represented by the formula (2):

【化7】 Embedded image

【0007】[3]式(3)で表される化合物。[3] A compound represented by the formula (3):

【化8】 Embedded image

【0008】[4]式(4)で表される化合物。[4] A compound represented by the formula (4):

【化9】 Embedded image

【0009】[5]式(5)[5] Equation (5)

【化10】 で表される化合物に、一般式(6)で表されるセレン化
合物を作用させることを特徴とする、前記[1]項に記
載の式(1)で表される化合物の製造方法。 M2Se2 (6) (式中、MはLi,NaまたはKである。)
Embedded image Wherein the selenium compound represented by the general formula (6) is caused to act on the compound represented by the general formula (6). M 2 Se 2 (6) (where M is Li, Na or K)

【0010】[6]前記[5]項において、一般式
(6)のMがNaである、前記[1]項に記載の式
(1)で表される化合物の製造方法。
[6] The method for producing a compound represented by the formula (1) according to the above item [1], wherein M in the general formula (6) is Na in the item [5].

【0011】[7]前記[1]項に記載の式(1)で表
される化合物に、一般式(7)で表される還元剤を作用
させることを特徴とする、前記[2]項に記載の式
(2)で表される化合物の製造方法。 MBH4 (7) (式中、MはLi、NaまたはKである。)
[7] The above item [2], wherein a compound represented by the general formula (7) is allowed to act on the compound represented by the formula (1) described in the above item [1]. A method for producing a compound represented by the formula (2) described in (1). MBH 4 (7) (where M is Li, Na or K)

【0012】[8]前記[7]項において、一般式
(7)のMがNaである、前記[2]項に記載の式
(2)で表される化合物の製造方法。
[8] The method for producing a compound represented by the formula (2) according to the above item [2], wherein M in the general formula (7) is Na in the item [7].

【0013】[9]前記[5]項に記載の式(5)で表
される化合物に、一般式(8)で表されるセレン化合物
を作用させることを特徴とする、前記[3]項に記載の
式(3)で表される化合物の製造方法。 MHSe (8) (式中、MはLi,NaまたはKである。)
[9] The item [3], wherein a selenium compound represented by the general formula (8) is allowed to act on the compound represented by the formula (5) described in the item [5]. The method for producing a compound represented by the formula (3) described in (1). MHSe (8) (where M is Li, Na or K)

【0014】[10]前記[9]項において、一般式
(8)のMがNaである、前記[3]項に記載の式
(3)で表される化合物の製造方法。
[10] The method for producing a compound represented by the formula (3) according to the above item [3], wherein M in the general formula (8) is Na in the above item [9].

【0015】[11]前記[3]項に記載の式(3)で
表される化合物に、有機過酸化物を作用させることを特
徴とする、前記[4]項に記載の式(4)で表される化
合物の製造方法。
[11] The compound represented by the formula (4) according to the above item [4], wherein an organic peroxide is allowed to act on the compound represented by the formula (3) according to the above item [3]. A method for producing a compound represented by the formula:

【0016】本発明が提供する蛋白質の変成剤として有
用な新規セレン化合物は、上記の式(1)で表される化
合物(以下、化合物(1)と略称する。)、式(2)で
表される化合物(以下、化合物(2)と略称する。)お
よび式(4)で表される化合物(以下、化合物(4)と
略称する。)である。また、式(3)で表される化合物
(以下、化合物(3)と略称する。)も新規に見出され
たものであり、これらはいずれも触媒としての作用も期
待される。
The novel selenium compound useful as a protein denaturant provided by the present invention is a compound represented by the above formula (1) (hereinafter abbreviated as compound (1)) or a compound represented by the formula (2). (Hereinafter abbreviated as compound (2)) and a compound represented by the formula (4) (hereinafter abbreviated as compound (4)). Further, a compound represented by the formula (3) (hereinafter, abbreviated as compound (3)) has also been newly discovered, and all of them are expected to act as a catalyst.

【0017】[0017]

【発明の実施の形態】本発明の化合物は、それぞれ以下
の方法で製造される。化合物(1)は、式(5)で表さ
れる化合物トランス−1,3−ブタジエンジエポキシド
と上記の一般式(6)で表されるセレン化合物、例えば
Na2Se2を作用させ、下記のScheme1に示す反
応経路によって得ることが出来る。
BEST MODE FOR CARRYING OUT THE INVENTION The compounds of the present invention are each produced by the following methods. The compound (1) is reacted with a compound trans-1,3-butadiene diepoxide represented by the formula (5) and a selenium compound represented by the above general formula (6), for example, Na 2 Se 2, and It can be obtained by the reaction route shown in Scheme 1.

【化11】 Embedded image

【0018】化合物(1)をメタノールに溶解し、上記
の一般式(7)で表される還元剤、例えば水素化ホウ素
ナトリウムで還元処理後、濃塩酸で処理することにより
化合物(2)に導くことが出来る(Scheme2)。
The compound (1) is dissolved in methanol, reduced with a reducing agent represented by the general formula (7), for example, sodium borohydride, and then treated with concentrated hydrochloric acid to obtain the compound (2). (Scheme 2).

【化12】 Embedded image

【0019】上記の例は出発物質にトランス−ブタジエ
ンジエポキシドを用いているが、これをシス−ブタジエ
ンジエポキシドに変更することにより、シス体の化合物
(1)および(2)を得ることが出来る。
In the above example, trans-butadiene diepoxide is used as a starting material, but cis-form compounds (1) and (2) can be obtained by changing this to cis-butadiene diepoxide. .

【0020】化合物(3)は、トランス−1,3−ブタ
ジエンジエポキシドと一般式(8)で表されるセレン化
合物、例えばNaHSeを作用させ、下記のSchem
e3に示す反応経路によって得ることが出来る。
The compound (3) is reacted with trans-1,3-butadiene diepoxide and a selenium compound represented by the general formula (8), for example, NaHSe, to give the following Schem.
It can be obtained by the reaction route shown in e3.

【化13】 Embedded image

【0021】化合物(3)は、過蟻酸、過酢酸、過安息
香酸、メタクロロ過安息香酸、またはt-ブチルペルオキ
シドなどの有機過酸化物を用いて酸化することにより、
化合物(4)へと変換することが出来る(Scheme
4)。
The compound (3) is oxidized by using an organic peroxide such as formic acid, peracetic acid, perbenzoic acid, metachloroperbenzoic acid, or t-butyl peroxide.
Can be converted to compound (4) (Scheme
4).

【化14】 Embedded image

【0022】上記の例も出発物質をトランス−ブタジエ
ンジエポキシドからシス−ブタジエンジエポキシドに変
更することにより、シス体の化合物(3)および(4)
を得ることが出来る。
In the above example, the starting material was changed from trans-butadiene diepoxide to cis-butadiene diepoxide to obtain cis-form compounds (3) and (4).
Can be obtained.

【0023】上記の一般式(6)または(8)で表され
るセレン化合物は、金属セレンを水中に懸濁させ、一般
式(7)で表される還元剤と反応させることにより得る
ことができる。このとき、金属セレンと一般式(7)で
表される還元剤とのモル比を1:1にすれば一般式
(6)で表されるセレン化合物が得られ、1:2で反応
させれば一般式(8)で表されるセレン化合物が得られ
る。
The selenium compound represented by the general formula (6) or (8) can be obtained by suspending metal selenium in water and reacting the metal selenium with a reducing agent represented by the general formula (7). it can. At this time, if the molar ratio of the metal selenium to the reducing agent represented by the general formula (7) is set to 1: 1, the selenium compound represented by the general formula (6) is obtained, and the reaction is performed at a ratio of 1: 2. For example, a selenium compound represented by the general formula (8) is obtained.

【0024】[0024]

【実施例】以下、実施例により本発明を更に詳しく説明
するが、本発明はこれらの実施例によって制限されるも
のではない。 実施例1 化合物(1)(1,2−ジセレナン−4,5−ジオー
ル)の合成 窒素気流下室温にて、セレン3.0g(38mmol)
を水25mLに懸濁させ、これに水素化ホウ素ナトリウ
ム3.0g(76mmol)を水25mLに溶かした溶
液をゆっくりと滴下した。10分後、セレン3.0g
(38mmol)を加え、更に15分間撹拌した。この
混合液をセレンが溶けるまで約1時間100℃で加熱し
た後室温になるまで冷却し、1,3−ブタジエンジエポ
キシド1.46mL(19mmol)を加えた。1時間
加熱還流の後、過剰の還元型セレン(Na2Se2)を酸
化するために空気中で一晩撹拌した。析出したセレンを
濾別後、水層をソックスレー抽出器を用いて連続エーテ
ル抽出し、目的化合物2.54gを得た。粗収率は54
%であった。得られた化合物(1)をメタノール5mL
より再結晶し、黄色柱状結晶を得た。
EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention. Example 1 Synthesis of compound (1) (1,2-diselenane-4,5-diol) 3.0 g (38 mmol) of selenium at room temperature under a nitrogen stream.
Was suspended in 25 mL of water, and a solution of 3.0 g (76 mmol) of sodium borohydride dissolved in 25 mL of water was slowly added dropwise thereto. 10 minutes later, 3.0 g of selenium
(38 mmol) was added and the mixture was further stirred for 15 minutes. The mixture was heated at 100 ° C. for about 1 hour until selenium was dissolved, then cooled to room temperature, and 1.46 mL (19 mmol) of 1,3-butadiene diepoxide was added. After heating and refluxing for 1 hour, the mixture was stirred overnight in air to oxidize excess reduced selenium (Na 2 Se 2 ). After separating the precipitated selenium by filtration, the aqueous layer was subjected to continuous ether extraction using a Soxhlet extractor to obtain 2.54 g of the target compound. The crude yield is 54
%Met. 5 mL of the obtained compound (1) is methanol
Further recrystallization gave yellow columnar crystals.

【0025】 融点116〜118℃1 H-NMR (in DMF-d7):d 3.16(m,2H),3.43(dd,2H),3.5
3(m,2H),5.20(d,2H)13 C-NMR (in DMF-d7):d 31.8,75.477 Se-NMR (in DMF-d7):d 268 (broad) IR (流動パラフィン法):3450,3319,1448,1412,12
82,1248,1120,997,968,843,760cm-1 元素分析:C 19.59%,H 3.14% (calc. C 19.53%,H 3.
28%)
1 H-NMR (in DMF-d7): d 3.16 (m, 2H), 3.43 (dd, 2H), 3.5
3 (m, 2H), 5.20 (d, 2H) 13 C-NMR (in DMF-d7): d 31.8, 75.4 77 Se-NMR (in DMF-d7): d 268 (broad) IR (liquid paraffin method) : 3450, 3319, 1448, 1412, 12
82, 1248, 1120, 997, 968, 843, 760 cm- 1 Elemental analysis: C 19.59%, H 3.14% (calc. C 19.53%, H 3.
(28%)

【0026】実施例2 化合物(3)(セレノラン−3,4−ジオール)の合成 窒素気流下室温において、セレン1.5g(19mmo
l)を水25mLに懸濁させ、これに水素化ホウ素ナト
リウム1.5g(38mmol)を水25mLに溶かし
た溶液をゆっくりと滴下した。15分間撹拌後、1,3
−ブタジエンジエポキシド1.2mL(16mmol)
を加えた。10分間室温で撹拌後、窒素ラインを取り外
し、空気中で一晩撹拌した。析出したセレンを濾別後、
水層をソックスレーを用いて連続エーテル抽出し、セレ
ノラン−3,4−ジオール1.44gを得た。粗収率は
55%であった。さらにクロロホルム5mLで再結晶
し、白色柱状結晶を得た。
Example 2 Synthesis of compound (3) (selenolan-3,4-diol) 1.5 g (19 mmol) of selenium at room temperature under a nitrogen stream.
l) was suspended in 25 mL of water, and a solution of 1.5 g (38 mmol) of sodium borohydride dissolved in 25 mL of water was slowly added dropwise. After stirring for 15 minutes,
-Butadiene diepoxide 1.2 mL (16 mmol)
Was added. After stirring at room temperature for 10 minutes, the nitrogen line was removed and the mixture was stirred in air overnight. After filtering off the precipitated selenium,
The aqueous layer was subjected to continuous ether extraction using Soxhlet to obtain 1.44 g of selenolane-3,4-diol. The crude yield was 55%. Further, recrystallization was performed with 5 mL of chloroform to obtain white columnar crystals.

【0027】融点79〜80℃1 H-NMR (in CDCl3):d 2.10(d,2H),2.87(dd,2H),3.16
(dd,2H),4.27(m,2H)13 C-NMR (in CDCl3):d 26.8,78.977 Se-NMR (in CDCl3):d 65.6 IR (流動パラフィン法):3305,1460,1377,1275,11
80,1134,1012,941,781cm-1 元素分析:C 28.55%,H 4.70% (calc. C 28.76%,H 4.
83%)
[0027] mp 79~80 ℃ 1 H-NMR (in CDCl3): d 2.10 (d, 2H), 2.87 (dd, 2H), 3.16
(dd, 2H), 4.27 (m, 2H) 13 C-NMR (in CDCl 3): d 26.8, 78.9 77 Se-NMR (in CDCl 3): d 65.6 IR (liquid paraffin method): 3305, 1460, 1377, 1275 , 11
80, 1134, 1012, 941, 781 cm -1 Elemental analysis: C 28.55%, H 4.70% (calc. C 28.76%, H 4.
(83%)

【0028】実施例3 化合物(4)(3,4−ジヒドロキシ−1−セレノラン
オキシド)の合成 実施例2で得られたセレノラン−3,4−ジオール5
4.7mg(0.33mmol)を塩化メチレン10m
Lに溶解し、この溶液にm−クロロ過安息香酸56.3
mg(0.33mmol)を塩化メチレン10mLに溶
かした溶液を加えて撹拌した。生じた白色沈殿を濾過し
て集め、目的化合物41.1mgを得た。粗収率は69
%であった。さらにメタノールより再結晶して白色柱状
結晶を得た。
Example 3 Synthesis of compound (4) (3,4-dihydroxy-1-selenolane oxide) Selenolane-3,4-diol 5 obtained in Example 2
4.7 mg (0.33 mmol) of methylene chloride 10m
L, and m-chloroperbenzoic acid 56.3 was added to this solution.
A solution of mg (0.33 mmol) in 10 mL of methylene chloride was added and stirred. The resulting white precipitate was collected by filtration to give 41.1 mg of the desired compound. The crude yield is 69
%Met. Recrystallization from methanol gave white columnar crystals.

【0029】融点123.8〜125.2℃1 H-NMR (in CDCl3):d 2.87(d,1H),3.08(dd,1H),3.58
(dd,1H),3.78(dd,1H),4.63(m,1H),4.72(dd,1H),4.8
0(s,2H)13 C-NMR (in CDCl3):d 55.0,58.0,79.1,79.577 Se-NMR (in CDCl3):d 941.8 元素分析:C 26.16%,H 4.17% (calc. C 26.24%,H 4.
405%)
Melting point 123.8-125.2 ° C. 1 H-NMR (in CDCl 3): d 2.87 (d, 1H), 3.08 (dd, 1H), 3.58
(dd, 1H), 3.78 (dd, 1H), 4.63 (m, 1H), 4.72 (dd, 1H), 4.8
0 (s, 2H) 13 C-NMR (in CDCl3): d 55.0, 58.0, 79.1, 79.5 77 Se-NMR (in CDCl3): d 941.8 Elemental analysis: C 26.16%, H 4.17% (calc. C 26.24% , H 4.
(405%)

【0030】実施例4 化合物(2)(2,3−ジヒドロキシ−1,4−ブタン
ジセレノール)の合成 実施例1で合成した1,2−ジセレナン−4,5−ジオ
ール68.6mg(0.279mmol)をメタノール
0.5mLに溶解し、この溶液に水素化ホウ素ナトリウ
ムを溶液の色が消失するまで加えた。反応液に6M塩酸
6mLとエーテル80mLを加えて1時間激しく撹拌し
ながらエーテル抽出した。抽出は2回行い、エーテル層
をシリンジで採取して硫酸マグネシウム上で乾燥した。
溶媒を留去し、白色結晶状の目的化合物を得た。
Example 4 Synthesis of compound (2) (2,3-dihydroxy-1,4-butanediselenol) 68.6 mg of 1,2-diselenane-4,5-diol synthesized in Example 1 (0.4%). 279 mmol) was dissolved in 0.5 mL of methanol, and sodium borohydride was added to the solution until the color of the solution disappeared. 6 mL of 6M hydrochloric acid and 80 mL of ether were added to the reaction solution, and ether extraction was performed with vigorous stirring for 1 hour. The extraction was performed twice, and the ether layer was collected with a syringe and dried over magnesium sulfate.
The solvent was distilled off to obtain a white crystalline target compound.

【0031】1H-NMR (in CDCl3):d -0.51(t,2H),2.82
(m,4H),4.27(m,2H)13 C-NMR (in CDCl3):d 22.6,80.777 Se-NMR (in CDCl3):d -78.3 元素分析:C 26.16%,H 4.17% (calc. C 26.24%,H 4.
405%)
1 H-NMR (in CDCl 3): d −0.51 (t, 2H), 2.82
(m, 4H), 4.27 ( m, 2H) 13 C-NMR (in CDCl3): d 22.6,80.7 77 Se-NMR (in CDCl3): d -78.3 Elemental analysis: C 26.16%, H 4.17% (calc. C 26.24%, H 4.
(405%)

【0032】比較例1 化合物(4)の酸化反応性 化合物(4)とDTT(1,4−ジメルカプト−2,3
−ブタンジオール)とを、1:1の比率でpH7.0の
緩衝液中に0.1M濃度で溶解したところ、速やかに化
合物(3)と1,2−ジチアン−4,5−ジオールに変
化した。すなわち、化合物(4)は強い酸化能力を持つ
ことが判った。
Comparative Example 1 Oxidation Reactivity of Compound (4) Compound (4) and DTT (1,4-dimercapto-2,3)
-Butanediol) was dissolved at a concentration of 0.1 M in a buffer solution having a pH of 1: 1 at a ratio of 1: 1 and rapidly changed to the compound (3) and 1,2-dithiane-4,5-diol. did. That is, it was found that the compound (4) had a strong oxidizing ability.

【0033】比較例2 緩衝液のpHを4.0に変更した以外は比較例1と同様
の操作を行ったところ、やはり化合物(3)と1,2−
ジチアン−4,5−ジオールが得られた。
Comparative Example 2 The same operation as in Comparative Example 1 was carried out except that the pH of the buffer was changed to 4.0.
Dithiane-4,5-diol was obtained.

【0034】比較例3 緩衝液のpHを8.0に変更した以外は比較例1と同様
の操作を行ったところ、やはり化合物(3)と1,2−
ジチアン−4,5−ジオールが得られた。
Comparative Example 3 The same operation as in Comparative Example 1 was carried out except that the pH of the buffer solution was changed to 8.0.
Dithiane-4,5-diol was obtained.

【0035】比較例4 DTTをグルタチオンに変更した以外は比較例1と同様
な操作を行ったところ、化合物(3)が得られた。グル
タチオンの酸化物は同定できなかった。
Comparative Example 4 The same operation as in Comparative Example 1 was carried out except that DTT was changed to glutathione, whereby a compound (3) was obtained. Glutathione oxide could not be identified.

【0036】比較例5 ジフェニルジスルフィド(PhSSPh)に対する反応
性 重メタノールを溶媒とし、NMRサンプル管に化合物
(2)とジフェニルジスルフィドを入れてNMR分析を
行ったところ、化合物(2)の消失と化合物(1)およ
びPhSHの生成が、lH、13C、77Se−NMRによ
って確認された。一方、DTTを用いた場合には、空気
酸化によると思われる1,2−ジチアン−4,5−ジオ
ールの生成がわずかに観測されたものの、PhSHの生
成は明確には確認できなかった。以上の結果より、化合
物(2)はDTTに比べ還元反応性が高いことが判っ
た。
Comparative Example 5 Reactivity to diphenyl disulfide (PhSSPh) Compound (2) and diphenyl disulfide were placed in an NMR sample tube using heavy methanol as a solvent, and NMR analysis was carried out. 1) and the formation of PhSH were confirmed by 1 H, 13 C, 77 Se-NMR. On the other hand, when DTT was used, although the production of 1,2-dithiane-4,5-diol, which was considered to be due to air oxidation, was slightly observed, the production of PhSH was not clearly confirmed. From the above results, it was found that the compound (2) had a higher reduction reactivity than DTT.

【0037】比較例6 文献(J.Am.Chem.Soc.,1994,11
6,2557)記載の方法に従い、メタノール中の過酸
化水素水および2当量のチオフェノールに、化合物
(1)を10mol%加えた。PhSSPhによる30
5nmのUV吸収強度の変化より,各時間におけるPh
SH濃度を求め,1/v対1/[PhSH]プロット
(Lineweaver−Burk Plot)より初
期反応速度を求めた。初期条件としては,[H22]=
30mM、[PhSH]=1mM、[catalys
t]=0.01mMとした。(H22の初期濃度の設定
が文献のTable 1とは異なる)。得られた初期反
応速度(v0)は、触媒なしの場合、5.2microMole/m
inであったのに対し、化合物(1)を添加した場合、
7.9microMole/minという値であった。
Comparative Example 6 Literature (J. Am. Chem. Soc., 1994, 11)
6,2557), 10 mol% of compound (1) was added to aqueous hydrogen peroxide and 2 equivalents of thiophenol in methanol. 30 by PhSSPh
From the change in UV absorption intensity at 5 nm, Ph at each time
The SH concentration was determined, and the initial reaction rate was determined from a 1 / v vs. 1 / [PhSH] plot (Lineweaver-Burk Plot). As initial conditions, [H 2 O 2 ] =
30 mM, [PhSH] = 1 mM, [catalys
t] = 0.01 mM. (Setting of the initial concentration of H 2 O 2 is different from Table 1 in the literature). The obtained initial reaction rate (v0) is 5.2 microMole / m when no catalyst is used.
Whereas, when compound (1) was added,
The value was 7.9 microMole / min.

【0038】比較例7 化合物(1)を化合物(3)に代えた以外は比較例6と
同様な操作を行ったところ、反応速度が8.4 microMo
le/minになった。
Comparative Example 7 The same operation as in Comparative Example 6 was carried out except that Compound (1) was replaced with Compound (3), and the reaction rate was 8.4 microMo.
le / min.

【0039】[0039]

【発明の効果】本発明により、従来の蛋白質変成剤であ
るDTTおよびその誘導体である1,2−ジチアン−
4,5−ジオールよりも、中性付近で高い反応性を持つ
新規なセレン化合物類を見出した。生体反応触媒として
の効果も期待される。
Industrial Applicability According to the present invention, the conventional protein denaturant DTT and its derivative 1,2-dithiane-
Novel selenium compounds having higher reactivity near neutrality than 4,5-diol have been found. An effect as a biological reaction catalyst is also expected.

Claims (11)

【特許請求の範囲】[Claims] 【請求項1】 式(1)で表される化合物。 【化1】 1. A compound represented by the formula (1). Embedded image 【請求項2】 式(2)で表される化合物。 【化2】 2. A compound represented by the formula (2). Embedded image 【請求項3】 式(3)で表される化合物。 【化3】 3. A compound represented by the formula (3). Embedded image 【請求項4】 式(4)で表される化合物。 【化4】 4. A compound represented by the formula (4). Embedded image 【請求項5】 式(5) 【化5】 で表される化合物に、一般式(6)で表されるセレン化
合物を作用させることを特徴とする、請求項1に記載の
式(1)で表される化合物の製造方法。 M2Se2 (6) (式中、MはLi,NaまたはKである。)
5. The formula (5) The method for producing a compound represented by the formula (1) according to claim 1, wherein a selenium compound represented by the general formula (6) is caused to act on the compound represented by the formula (6). M 2 Se 2 (6) (where M is Li, Na or K)
【請求項6】 請求項5において、一般式(6)のMが
Naである、請求項1に記載の式(1)で表される化合
物の製造方法。
6. The method for producing a compound represented by the formula (1) according to claim 1, wherein M in the general formula (6) is Na.
【請求項7】 請求項1に記載の式(1)で表される化
合物に、一般式(7)で表される還元剤を作用させるこ
とを特徴とする、請求項2に記載の式(2)で表される
化合物の製造方法。 MBH4 (7) (式中、MはLi、NaまたはKである。)
7. The compound according to claim 2, wherein the compound represented by the formula (1) according to claim 1 is reacted with a reducing agent represented by the formula (7). A method for producing the compound represented by 2). MBH 4 (7) (where M is Li, Na or K)
【請求項8】 請求項7において、一般式(7)のMが
Naである、請求項2に記載の式(2)で表される化合
物の製造方法。
8. The method for producing a compound represented by the formula (2) according to claim 2, wherein M in the general formula (7) is Na.
【請求項9】 請求項5に記載の式(5)で表される化
合物に、一般式(8)で表されるセレン化合物を作用さ
せることを特徴とする、請求項3に記載の式(3)で表
される化合物の製造方法。 MHSe (8) (式中、MはLi,NaまたはKである。)
9. The compound according to claim 3, wherein the selenium compound represented by the general formula (8) acts on the compound represented by the formula (5) according to claim 5. A method for producing the compound represented by 3). MHSe (8) (where M is Li, Na or K)
【請求項10】 請求項9において、一般式(8)のM
がNaである、請求項3に記載の式(3)で表される化
合物の製造方法。
10. The method according to claim 9, wherein M
Is a method for producing a compound represented by the formula (3) according to claim 3.
【請求項11】 請求項3に記載の式(3)で表される
化合物に、有機過酸化物を作用させることを特徴とす
る、請求項4に記載の式(4)で表される化合物の製造
方法。
11. The compound represented by the formula (4) according to claim 4, wherein an organic peroxide is allowed to act on the compound represented by the formula (3) according to claim 3. Manufacturing method.
JP24168699A 1999-08-27 1999-08-27 New selenium compounds Expired - Fee Related JP4433521B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24168699A JP4433521B2 (en) 1999-08-27 1999-08-27 New selenium compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24168699A JP4433521B2 (en) 1999-08-27 1999-08-27 New selenium compounds

Publications (2)

Publication Number Publication Date
JP2001064279A true JP2001064279A (en) 2001-03-13
JP4433521B2 JP4433521B2 (en) 2010-03-17

Family

ID=17078018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24168699A Expired - Fee Related JP4433521B2 (en) 1999-08-27 1999-08-27 New selenium compounds

Country Status (1)

Country Link
JP (1) JP4433521B2 (en)

Also Published As

Publication number Publication date
JP4433521B2 (en) 2010-03-17

Similar Documents

Publication Publication Date Title
JP2004534053A (en) Crystalline cefdinir acid addition salt and method for producing cefdinir using the same
JP2020097607A (en) Novel manufacturing method of chromanone derivative
CN102939298B (en) Prepare the method for pteridine derivatives
JPH0150704B2 (en)
WO2005035538A1 (en) Penam crystal and process for producing the same
KR20030060901A (en) A process for the preparation of pantoprazole and intermediates therefor
US7244865B2 (en) Process for preparing benzhydrylthioacetamide
EP1503983B1 (en) A process for the preparation of modafinil
JP4433521B2 (en) New selenium compounds
JPWO1996019448A1 (en) Method for producing bis(4-alkylthiophenyl) disulfide
US7109353B2 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl
CN101163671A (en) The preparation method of hydrazone derivative
EP1678129B1 (en) Improved process for preparing benzhydrylthioacetamide
EP0675877A1 (en) A process for preparing sulfones
JP2003508521A (en) Method for producing 1-substituted 5-hydroxymethylimidazole
EP3162795B1 (en) Method for manufacturing 3-(alkyl sulfonyl)pyridine-2-carboxylic acid
CN103497159B (en) 1,2-bis-replaces the preparation method of-5-sulfonylimidazoles compounds
CN121108046A (en) A method for preparing 3-hydroxylated quinoline-2,4-dione compounds
WO2025257737A1 (en) Process for the preparation of urolithin a and analogues thereof
KR100502390B1 (en) Process for preparing cephalosporinic acid
JPH0480918B2 (en)
JPS6254303B2 (en)
JP2003002878A (en) Method for preparing 2-aminophenoxazin-3-one derivative or 3-aminophenoxazin-2-one derivative
JP2002003491A (en) Method for producing 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine
JPH0532649A (en) Production of optically active benzyl glycidyl ether

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060609

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091208

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091221

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130108

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130108

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130108

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130108

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140108

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees